These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10797574)

  • 21. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
    Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
    J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal Cdc2-like kinases: neuron-specific forms of Cdk5.
    Lee KY; QI Z; Yu YP; Wang JH
    Int J Biochem Cell Biol; 1997 Jul; 29(7):951-8. PubMed ID: 9375376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel yeast protein showing specific association with the cyclin-dependent kinase 5.
    Huang QQ; Lee KY; Wang JH
    FEBS Lett; 1996 Jan; 378(1):48-50. PubMed ID: 8549800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
    Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
    Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
    Otyepka M; Bártová I; Kríz Z; Koca J
    J Biol Chem; 2006 Mar; 281(11):7271-81. PubMed ID: 16407256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cdk7 functions as a cdk5 activating kinase in brain.
    Rosales J; Han B; Lee KY
    Cell Physiol Biochem; 2003; 13(5):285-96. PubMed ID: 14586172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons.
    Morabito MA; Sheng M; Tsai LH
    J Neurosci; 2004 Jan; 24(4):865-76. PubMed ID: 14749431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells.
    Zheng YL; Li BS; Amin ND; Albers W; Pant HC
    Eur J Biochem; 2002 Sep; 269(18):4427-34. PubMed ID: 12230554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reconstitution of neuronal Cdc2-like kinase from bacteria-expressed Cdk5 and an active fragment of the brain-specific activator. Kinase activation in the absence of Cdk5 phosphorylation.
    Qi Z; Huang QQ; Lee KY; Lew J; Wang JH
    J Biol Chem; 1995 May; 270(18):10847-54. PubMed ID: 7738023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles.
    Tomizawa K; Sunada S; Lu YF; Oda Y; Kinuta M; Ohshima T; Saito T; Wei FY; Matsushita M; Li ST; Tsutsui K; Hisanaga S; Mikoshiba K; Takei K; Matsui H
    J Cell Biol; 2003 Nov; 163(4):813-24. PubMed ID: 14623869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cdk5 is essential for synaptic vesicle endocytosis.
    Tan TC; Valova VA; Malladi CS; Graham ME; Berven LA; Jupp OJ; Hansra G; McClure SJ; Sarcevic B; Boadle RA; Larsen MR; Cousin MA; Robinson PJ
    Nat Cell Biol; 2003 Aug; 5(8):701-10. PubMed ID: 12855954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic localization of p39, a neuronal activator of cdk5.
    Humbert S; Lanier LM; Tsai LH
    Neuroreport; 2000 Jul; 11(10):2213-6. PubMed ID: 10923673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division.
    Lacy ER; Wang Y; Post J; Nourse A; Webb W; Mapelli M; Musacchio A; Siuzdak G; Kriwacki RW
    J Mol Biol; 2005 Jun; 349(4):764-73. PubMed ID: 15890360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
    Shelton SB; Krishnamurthy P; Johnson GV
    J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
    Cruz JC; Tseng HC; Goldman JA; Shih H; Tsai LH
    Neuron; 2003 Oct; 40(3):471-83. PubMed ID: 14642273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MAP1B phosphorylation is differentially regulated by Cdk5/p35, Cdk5/p25, and JNK.
    Kawauchi T; Chihama K; Nishimura YV; Nabeshima Y; Hoshino M
    Biochem Biophys Res Commun; 2005 May; 331(1):50-5. PubMed ID: 15845356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A brain-specific activator of cyclin-dependent kinase 5.
    Lew J; Huang QQ; Qi Z; Winkfein RJ; Aebersold R; Hunt T; Wang JH
    Nature; 1994 Sep; 371(6496):423-6. PubMed ID: 8090222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity.
    Tomizawa K; Ohta J; Matsushita M; Moriwaki A; Li ST; Takei K; Matsui H
    J Neurosci; 2002 Apr; 22(7):2590-7. PubMed ID: 11923424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation.
    Saito T; Onuki R; Fujita Y; Kusakawa G; Ishiguro K; Bibb JA; Kishimoto T; Hisanaga S
    J Neurosci; 2003 Feb; 23(4):1189-97. PubMed ID: 12598607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.